Methyl 2,2,3,3,4,4,5,5,6,6,6-undecafluorohexanoate, 95.0%, 25g

(1R,3S)-3-((tert-butoxycarbonyl)amino)cyclopentyl acetate compound with (1S,3R)-3-((tert-butoxycarbonyl)amino)cyclopentyl acetate, 98%, 1g

4H-Indeno[1,2-b]thiophen-4-one>98.0%(GC)1g

4-(2,4-Difluorophenoxy)piperidine, 97%, 25g

7-Dimethylaminocoumarin-4-acetic acid, 95.0%, 1g

4-Bromo-2,5-dichloroiodobenzene, 95.0%, 250mg

2-Chloro-6-fluoro-3-methoxy-DL-phenylalanine, 1g

Methyl 3-(4-Hydroxyphenyl)propionate>98.0%(GC)25g

5,7-Dibromo-2,3-dihydrothieno[3,4-b][1,4]dioxine, 95.0%, 10g

Solution étalon ICP de potassium, 500 mL, 10 000 mg/L K, PEHD

ethyl 4-(3-methylphenyl)-3-oxobutanoate, 95.0%, 2g

(E)-3-(2,3-DIHYDROBENZOFURAN-7-YL)ACRYLIC ACID, 98%, 1g

1-Methyl-4-(2,2,2-trifluoroethyl)benzene, 95.0%, 1g